GUARD — Guard Therapeutics International AB (publ) Balance Sheet
0.000.00%
- SEK27.23m
- -SEK42.53m
Annual balance sheet for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 90 | 189 | 201 | 83.7 | 54.2 |
| Net Total Receivables | 0.709 | 0.931 | 0.897 | 0.667 | 0.422 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 91.2 | 190 | 203 | 85.2 | 55.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.044 | 0.029 | 0.015 | 0 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 91.2 | 190 | 203 | 85.2 | 55.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.5 | 10.9 | 22.7 | 16.6 | 17.7 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.5 | 14.7 | 25.2 | 18.5 | 17.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 79.7 | 176 | 177 | 66.7 | 38 |
| Total Liabilities & Shareholders' Equity | 91.2 | 190 | 203 | 85.2 | 55.7 |
| Total Common Shares Outstanding |